Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
36.67
+1.20 (3.38%)
At close: Aug 13, 2025, 4:00 PM
36.87
+0.20 (0.55%)
Pre-market: Aug 14, 2025, 8:39 AM EDT
HRMY Employees
Harmony Biosciences Holdings had 268 employees as of December 31, 2024. The number of employees increased by 22 or 8.94% compared to the previous year.
Employees
268
Change (1Y)
22
Growth (1Y)
8.94%
Revenue / Employee
$2,882,563
Profits / Employee
$675,015
Market Cap
2.11B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HRMY News
- 8 days ago - Harmony Biosciences Holdings, Inc. (HRMY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Harmony Biosciences Reports Strong Q2 2025 Financial Results and Reaffirms 2025 Revenue Guidance; On Track to Announce Fragile X Topline Data From Phase 3 Registrational Trial in Q3 2025 - Business Wire
- 23 days ago - Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - Business Wire
- 4 weeks ago - Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series - Business Wire
- 2 months ago - Harmony Biosciences Presents Preclinical Data Demonstrating Significant Wake-Promoting and Cataplexy-Suppressing Effects of BP1.15205 in Narcolepsy at SLEEP 2025 - Business Wire
- 2 months ago - Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation - Business Wire
- 2 months ago - Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - Business Wire
- 3 months ago - Harmony Biosciences Holdings, Inc. (HRMY) Q1 2025 Earnings Call Transcript - Seeking Alpha